Datapharm
A leading medicines information firm providing regulatory and compliance software solutions to the life sciences industry.
A leading medicines information firm providing regulatory and compliance software solutions to the life sciences industry.
- Sector
- Life Sciences
- HQ
- Leatherhead, UK
- Investment Year
- 2022
- Investment Status
- Current Investment
- Website
- datapharm.com
The Company
Datapharm is a medicines information company that provides technology-enabled solutions to the global life sciences and wider healthcare sectors. Its regulatory, compliance and commercial software solutions facilitate the accessibility and usability of medicines information to healthcare professionals and patients.
CGE’s Investment
CGE partnered with Datapharm’s management team to accelerate new product development, international expansion, and strategic acquisitions. Since our investment, Datapharm has redefined its product proposition to deliver integrated regulatory solutions and undertaken a significant technology overhaul to support future innovation. In July 2024, Datapharm completed a strategic acquisition to support its entry into new European markets.
Datapharm’s Purpose
Transforming the accessibility and effectiveness of trusted medicine information.
We are thrilled to be partnering with CGE to improve the accessibility of medicines information, ultimately leading to better patient outcomes. Thanks to CGE’s investment, Datapharm has already achieved BCorp status, restructured and re-platformed our flagship product, and made a strategic acquisition. I look forward to our ongoing partnership as we work together to achieve our shared goals.
Richard Cooper, CEO of Datapharm
